Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Gross Margin (2021 - 2025)

Lucid Diagnostics' Gross Margin history spans 5 years, with the latest figure at 24.0% for Q4 2025.

  • For Q4 2025, Gross Margin rose 21050.0% year-over-year to 24.0%; the TTM value through Dec 2025 reached 94.35%, up 12608.0%, while the annual FY2025 figure was 41.91%, 23689.0% up from the prior year.
  • Gross Margin reached 24.0% in Q4 2025 per LUCD's latest filing, up from 41.42% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 678.56% in Q4 2023 to a low of 2435.85% in Q2 2023.
  • Average Gross Margin over 5 years is 237.2%, with a median of 65.43% recorded in 2024.
  • The largest YoY upside for Gross Margin was 210450bps in 2024 against a maximum downside of -91306bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 100.0% in 2021, then changed by 0bps to 100.0% in 2022, then surged by 579bps to 678.56% in 2023, then plummeted by -135bps to 234.5% in 2024, then skyrocketed by 90bps to 24.0% in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Gross Margin are 24.0% (Q4 2025), 41.42% (Q3 2025), and 30.25% (Q2 2025).